MiR-372-3p Functions as a Tumor Suppressor in Colon Cancer by Targeting MAP3K2.

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
• miR-372 is part of the miR-371-373 gene cluster and implicated in various cancers.
• The specific role of miR-372 in colon cancer pathogenesis requires elucidation.

Purpose of the Study:

• To investigate the expression levels of miR-372-3p in colon cancer.
• To determine the functional role of miR-372-3p in colon cancer cell growth and proliferation.
• To identify the molecular targets of miR-372-3p in colon cancer.

Main Methods:

• Real-time quantitative polymerase chain reaction (qPCR) to assess miR-372-3p expression in 153 colon cancer and adjacent normal tissues.
• Cell proliferation assays in SW480 colon cancer cells with modulated miR-372-3p levels.
• Luciferase reporter assays to validate the direct targeting of MAP3K2 by miR-372-3p.

Main Results:

• miR-372-3p expression was significantly reduced (>2-fold) in 51.5% of colon cancer tissues compared to normal tissues.
• Overexpression of miR-372-3p suppressed colon cancer cell growth and proliferation.
• An inverse correlation was observed between miR-372-3p and Ki67 (proliferation marker) and MAP3K2 (MEKK2).
• Luciferase assays confirmed that miR-372-3p directly targets the 3'-UTR of MAP3K2, inhibiting its expression.

Conclusions:

• miR-372-3p functions as a tumor suppressor in colon cancer.
• The tumor-suppressive activity of miR-372-3p is mediated through the direct targeting of MAP3K2.
• Restoration of miR-372-3p levels may represent a potential therapeutic strategy for colon cancer.